Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Historical Trends in the Diagnosis of Peduncular Hallucinosis.

Galetta KM, Prasad S.

J Neuroophthalmol. 2018 Dec;38(4):438-441. doi: 10.1097/WNO.0000000000000599.

PMID:
29215387
2.

20/40 or Better Visual Acuity After Optic Neuritis: Not as Good as We Once Thought?

Sabadia SB, Nolan RC, Galetta KM, Narayana KM, Wilson JA, Calabresi PA, Frohman EM, Galetta SL, Balcer LJ.

J Neuroophthalmol. 2016 Dec;36(4):369-376.

PMID:
27472185
3.

Screening Utility of the King-Devick Test in Mild Cognitive Impairment and Alzheimer Disease Dementia.

Galetta KM, Chapman KR, Essis MD, Alosco ML, Gillard D, Steinberg E, Dixon D, Martin B, Chaisson CE, Kowall NW, Tripodis Y, Balcer LJ, Stern RA.

Alzheimer Dis Assoc Disord. 2017 Apr-Jun;31(2):152-158. doi: 10.1097/WAD.0000000000000157.

4.

Varicella Zoster Virus Infection in Granulomatous Arteritis of the Aorta.

Gilden D, White T, Boyer PJ, Galetta KM, Hedley-Whyte ET, Frank M, Holmes D, Nagel MA.

J Infect Dis. 2016 Jun 15;213(12):1866-71. doi: 10.1093/infdis/jiw101. Epub 2016 Mar 31.

5.

Zeroing in on zoster: A tale of many disorders produced by one virus.

Galetta KM, Gilden D.

J Neurol Sci. 2015 Nov 15;358(1-2):38-45. doi: 10.1016/j.jns.2015.10.004. Epub 2015 Oct 3. Review.

6.

The King-Devick test of rapid number naming for concussion detection: meta-analysis and systematic review of the literature.

Galetta KM, Liu M, Leong DF, Ventura RE, Galetta SL, Balcer LJ.

Concussion. 2015 Sep 10;1(2):CNC8. doi: 10.2217/cnc.15.8. eCollection 2016 Mar. Review.

7.

Quality of life in idiopathic intracranial hypertension at diagnosis: IIH Treatment Trial results.

Digre KB, Bruce BB, McDermott MP, Galetta KM, Balcer LJ, Wall M; NORDIC Idiopathic Intracranial Hypertension Study Group.

Neurology. 2015 Jun 16;84(24):2449-56. doi: 10.1212/WNL.0000000000001687. Epub 2015 May 20.

8.

Adding Vision to Concussion Testing: A Prospective Study of Sideline Testing in Youth and Collegiate Athletes.

Galetta KM, Morganroth J, Moehringer N, Mueller B, Hasanaj L, Webb N, Civitano C, Cardone DA, Silverio A, Galetta SL, Balcer LJ.

J Neuroophthalmol. 2015 Sep;35(3):235-41. doi: 10.1097/WNO.0000000000000226.

PMID:
25742059
9.

Vision testing is additive to the sideline assessment of sports-related concussion.

Marinides Z, Galetta KM, Andrews CN, Wilson JA, Herman DC, Robinson CD, Smith MS, Bentley BC, Galetta SL, Balcer LJ, Clugston JR.

Neurol Clin Pract. 2015 Feb;5(1):25-34. doi: 10.1212/CPJ.0000000000000060.

10.

Monocular and binocular low-contrast visual acuity and optical coherence tomography in pediatric multiple sclerosis.

Waldman AT, Hiremath G, Avery RA, Conger A, Pineles SL, Loguidice MJ, Talman LS, Galetta KM, Shumski MJ, Wilson J, Ford E, Lavery AM, Conger D, Greenberg BM, Ellenberg JH, Frohman EM, Balcer LJ, Calabresi PA.

Mult Scler Relat Disord. 2013 May 1;3(3):326-334.

11.

Sports-related concussion: Anonymous survey of a collegiate cohort.

Torres DM, Galetta KM, Phillips HW, Dziemianowicz EM, Wilson JA, Dorman ES, Laudano E, Galetta SL, Balcer LJ.

Neurol Clin Pract. 2013 Aug;3(4):279-287.

12.

Measures of visual pathway structure and function in MS: Clinical usefulness and role for MS trials.

Galetta KM, Balcer LJ.

Mult Scler Relat Disord. 2013 Jul;2(3):172-82. doi: 10.1016/j.msard.2012.12.004. Epub 2013 Jan 30. Review.

PMID:
25877723
13.

Saccades and memory: baseline associations of the King-Devick and SCAT2 SAC tests in professional ice hockey players.

Galetta MS, Galetta KM, McCrossin J, Wilson JA, Moster S, Galetta SL, Balcer LJ, Dorshimer GW, Master CL.

J Neurol Sci. 2013 May 15;328(1-2):28-31. doi: 10.1016/j.jns.2013.02.008. Epub 2013 Mar 15.

PMID:
23499425
14.

Ganglion cell loss in relation to visual disability in multiple sclerosis.

Walter SD, Ishikawa H, Galetta KM, Sakai RE, Feller DJ, Henderson SB, Wilson JA, Maguire MG, Galetta SL, Frohman E, Calabresi PA, Schuman JS, Balcer LJ.

Ophthalmology. 2012 Jun;119(6):1250-7. doi: 10.1016/j.ophtha.2011.11.032. Epub 2012 Feb 23.

15.

Visual pathway axonal loss in benign multiple sclerosis: a longitudinal study.

Galetta KM, Graves J, Talman LS, Lile DJ, Frohman EM, Calabresi PA, Galetta SL, Balcer LJ.

J Neuroophthalmol. 2012 Jun;32(2):116-23. doi: 10.1097/WNO.0b013e318240204d.

16.

Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection.

Sakai RE, Feller DJ, Galetta KM, Galetta SL, Balcer LJ.

J Neuroophthalmol. 2011 Dec;31(4):362-73. doi: 10.1097/WNO.0b013e318238937f. Review.

17.

The King-Devick test and sports-related concussion: study of a rapid visual screening tool in a collegiate cohort.

Galetta KM, Brandes LE, Maki K, Dziemianowicz MS, Laudano E, Allen M, Lawler K, Sennett B, Wiebe D, Devick S, Messner LV, Galetta SL, Balcer LJ.

J Neurol Sci. 2011 Oct 15;309(1-2):34-9. doi: 10.1016/j.jns.2011.07.039. Epub 2011 Aug 16.

PMID:
21849171
18.

Retinal ganglion cell layer volumetric assessment by spectral-domain optical coherence tomography in multiple sclerosis: application of a high-precision manual estimation technique.

Davies EC, Galetta KM, Sackel DJ, Talman LS, Frohman EM, Calabresi PA, Galetta SL, Balcer LJ.

J Neuroophthalmol. 2011 Sep;31(3):260-4. doi: 10.1097/WNO.0b013e318221b434.

19.

The King-Devick test as a determinant of head trauma and concussion in boxers and MMA fighters.

Galetta KM, Barrett J, Allen M, Madda F, Delicata D, Tennant AT, Branas CC, Maguire MG, Messner LV, Devick S, Galetta SL, Balcer LJ.

Neurology. 2011 Apr 26;76(17):1456-62. doi: 10.1212/WNL.0b013e31821184c9. Epub 2011 Feb 2.

20.

Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration.

Galetta KM, Calabresi PA, Frohman EM, Balcer LJ.

Neurotherapeutics. 2011 Jan;8(1):117-32. doi: 10.1007/s13311-010-0005-1. Review.

21.

Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis.

Talman LS, Bisker ER, Sackel DJ, Long DA Jr, Galetta KM, Ratchford JN, Lile DJ, Farrell SK, Loguidice MJ, Remington G, Conger A, Frohman TC, Jacobs DA, Markowitz CE, Cutter GR, Ying GS, Dai Y, Maguire MG, Galetta SL, Frohman EM, Calabresi PA, Balcer LJ.

Ann Neurol. 2010 Jun;67(6):749-60. doi: 10.1002/ana.22005.

22.

Validation and test characteristics of a 10-item neuro-ophthalmic supplement to the NEI-VFQ-25.

Raphael BA, Galetta KM, Jacobs DA, Markowitz CE, Liu GT, Nano-Schiavi ML, Galetta SL, Maguire MG, Mangione CM, Globe DR, Balcer LJ.

Am J Ophthalmol. 2006 Dec;142(6):1026-35. Epub 2006 Oct 13.

Supplemental Content

Loading ...
Support Center